<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-946</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ В БИОЛОГИИ И МЕДИЦИНЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL RESEARCHES IN BIOLOGY AND MEDICINE</subject></subj-group></article-categories><title-group><article-title>ЦИТОТОКСИЧЕСКАЯ АКТИВНОСТЬ ДЕНДРИТНЫХ КЛЕТОК ПРОТИВ АКТИВИРОВАННЫХ CD4+ И CD8 Т-ЛИМФОЦИТОВ В КУЛЬТУРЕ IN VITRO</article-title><trans-title-group xml:lang="en"><trans-title>CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тыринова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyrinova</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">tyrinova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леплина</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Leplina</surname><given-names>O. Yu.</given-names></name></name-alternatives><email xlink:type="simple">oleplina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихонова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tihonova</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Останин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostanin</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>E. R.</given-names></name></name-alternatives><email xlink:type="simple">bmt-novosibirsk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ клинической иммунологии СО РАМН</institution></aff><aff xml:lang="en"><institution>Institute of Clinical Immunology SB RAMS</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2012</year></pub-date><volume>0</volume><issue>3(2)</issue><fpage>327</fpage><lpage>331</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тыринова Т.В., Леплина О.Ю., Тихонова М.А., Останин А.А., Черных Е.Р., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Тыринова Т.В., Леплина О.Ю., Тихонова М.А., Останин А.А., Черных Е.Р.</copyright-holder><copyright-holder xml:lang="en">Tyrinova T.V., Leplina O.Y., Tihonova M.A., Ostanin A.A., Chernykh E.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/946">https://www.actabiomedica.ru/jour/article/view/946</self-uri><abstract><p>Целью настоящего исследования явилась сравнительная оценка цитотоксической активности IFNα-индуцированных дендритных клеток (ИФН-ДК) и IL-4-индуцированных ДК (ИЛ4-ДК) против активированных в алло-СКЛ CD4+ и CD8+ Т-лимфоцитов. Показано, что в культурах с ИФН-ДК доля AnnexinV+/PI'клеток, соответствующих ранней стадии апоптоза, среди CD4+Т-лимфоцитов была ниже, чем в культурах с ИЛ4-ДК. В то же время относительное количество AnnexinV+/PI+клеток (поздняя фаза апоптоза/некроз) среди CD4+Т-клеток после активации аллогенными ИФН-ДК и ИЛ4-ДК возрастало в равной степени. Продемонстрировано, что ИФН-ДК обладали сходной c ИЛ4-ДК способностью индуцировать апоптоз в CD3+CD8+Т-клетках.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the present study was a comparative assessment of the cytotoxic activity of IFNα-induced dendritic cells (IFN-DCs) and IL-4-induced DCs (IL4-DCs) against allo-MLC- activated CD4+ and CD8+T-lymphocytes. It was shown the level of AnnexinV+/PI- cells corresponding to early apoptosis among CD4+T-lymphocytes was lower in cultures with IFN-DCs compared with IL4-DCs. At the same time the relative number of AnnexinV+/ PI+ cells (late phase of apoptosis/necrosis) among CD4+T-lymphocytes activated by allogenic IFN-DCs and IL4-DCs increased in an equal degree. It was demonstrated that IFN-DCs possesed similar ability to induce apoptosis of CD3+CD8+T-lymphocytes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дендритные клетки</kwd><kwd>апоптоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>CD4+T-лимфоциты</kwd><kwd>CD8+T-лимфоциты</kwd><kwd>dendritic cells</kwd><kwd>CD4+ T-lymphocytes</kwd><kwd>CD8+T-lymphocytes</kwd><kwd>apoptosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Леплина О.Ю., Тихонова М.А., Тыринова Т.В. Сравнительная характеристика фенотипа и цитокин-секреторной активности дендритных клеток человека, генерируемых in vitro в присутствии IFN-альфа и IL-4 // Иммунология. — 2012. — № 1. — С. 36 — 46.</mixed-citation><mixed-citation xml:lang="en">Леплина О.Ю., Тихонова М.А., Тыринова Т.В. Сравнительная характеристика фенотипа и цитокин-секреторной активности дендритных клеток человека, генерируемых in vitro в присутствии IFN-альфа и IL-4 // Иммунология. — 2012. — № 1. — С. 36 — 46.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bosque A., Pardo J., Martmez-Lorenzo M.J. Human CD8+T cell blasts are more sensitive than CD4+T cell blasts to regulation by APO2L/TRAIL // Eur. J. Immunol. — 2005. — Vol. 35. — P. 1812—1821.</mixed-citation><mixed-citation xml:lang="en">Bosque A., Pardo J., Martmez-Lorenzo M.J. Human CD8+T cell blasts are more sensitive than CD4+T cell blasts to regulation by APO2L/TRAIL // Eur. J. Immunol. — 2005. — Vol. 35. — P. 1812—1821.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta S., Su H., Bi R. Life and death of lymphocytes: a role in immunesenescence // Immunity &amp; Ageing. — 2005. — Vol. 2. — P. 12.</mixed-citation><mixed-citation xml:lang="en">Gupta S., Su H., Bi R. Life and death of lymphocytes: a role in immunesenescence // Immunity &amp; Ageing. — 2005. — Vol. 2. — P. 12.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hoves S., Krause S.W., Herfarth H. Elimination of activated but not resting primary human CD4 + and CD8+T cells by Fas ligand (FasL/CD95L)-expressing killer-dendritic cells // Immunobiology. — 2004. — Vol. 208. — P. 463 — 475.</mixed-citation><mixed-citation xml:lang="en">Hoves S., Krause S.W., Herfarth H. Elimination of activated but not resting primary human CD4 + and CD8+T cells by Fas ligand (FasL/CD95L)-expressing killer-dendritic cells // Immunobiology. — 2004. — Vol. 208. — P. 463 — 475.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lapenta C., Santini S., Spada M. IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8 + T cells against exogenous viral antigens // Eur. J. Immunol. — 2006. — Vol. 36. — P. 2046 — 2060.</mixed-citation><mixed-citation xml:lang="en">Lapenta C., Santini S., Spada M. IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8 + T cells against exogenous viral antigens // Eur. J. Immunol. — 2006. — Vol. 36. — P. 2046 — 2060.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Leplina O., Tyrinova T., Tikhonova M. Direct Antitumor Activity of Interferon-Induced Dendritic Cells of Healthy Donors and Patients with Primary Brain Tumors // Glioma — Exploring Its Biology and Practical Relevance. — 2011. — P. 325 — 342.</mixed-citation><mixed-citation xml:lang="en">Leplina O., Tyrinova T., Tikhonova M. Direct Antitumor Activity of Interferon-Induced Dendritic Cells of Healthy Donors and Patients with Primary Brain Tumors // Glioma — Exploring Its Biology and Practical Relevance. — 2011. — P. 325 — 342.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Luckey U., Maurer M., Schmidt T. T cell killing by tolerogenic dendritic cells protects mice from allergy // J. Clin. Invest. — 2011. — Vol. 121, N 10. — P. 3860 — 3871.</mixed-citation><mixed-citation xml:lang="en">Luckey U., Maurer M., Schmidt T. T cell killing by tolerogenic dendritic cells protects mice from allergy // J. Clin. Invest. — 2011. — Vol. 121, N 10. — P. 3860 — 3871.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Maciejewski J., Selleri C., Anderson S., Young N.S. Fas antigen expression on CD34 + human marrow cells induced by interferon-γ and tumor necrosis-α and potentiated cytokine mediated hemopoietic suppression in vitro // Blood. — 1995. — Vol. 85. — P. 3183 — 3190.</mixed-citation><mixed-citation xml:lang="en">Maciejewski J., Selleri C., Anderson S., Young N.S. Fas antigen expression on CD34 + human marrow cells induced by interferon-γ and tumor necrosis-α and potentiated cytokine mediated hemopoietic suppression in vitro // Blood. — 1995. — Vol. 85. — P. 3183 — 3190.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mirandola P., Ponti C., Gobbi G. Activated human NK and CD8 + T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity // Blood. — 2004. — Vol. 104, N 8. — P. 2418 — 2424.</mixed-citation><mixed-citation xml:lang="en">Mirandola P., Ponti C., Gobbi G. Activated human NK and CD8 + T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity // Blood. — 2004. — Vol. 104, N 8. — P. 2418 — 2424.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rissoan M.C., Duhen T., Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action therapeutic implications for cancer // Cell Death Differ. — 2008. — Vol. 15. — P. 51—57.</mixed-citation><mixed-citation xml:lang="en">Rissoan M.C., Duhen T., Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action therapeutic implications for cancer // Cell Death Differ. — 2008. — Vol. 15. — P. 51—57.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Raftery M.J., Schwab M., Eibert S.M. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy // Immunity. — 2001. — Vol. 15. — P. 997 — 1009.</mixed-citation><mixed-citation xml:lang="en">Raftery M.J., Schwab M., Eibert S.M. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy // Immunity. — 2001. — Vol. 15. — P. 997 — 1009.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Santini S., Pucchini T., Lapenta C. A new type IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells // Stem cells. — 2003. — Vol. 21. — P. 357 — 362.</mixed-citation><mixed-citation xml:lang="en">Santini S., Pucchini T., Lapenta C. A new type IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells // Stem cells. — 2003. — Vol. 21. — P. 357 — 362.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection // Nature Immunology. — 2007. — Vol. 8. — P. 239 — 245.</mixed-citation><mixed-citation xml:lang="en">Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection // Nature Immunology. — 2007. — Vol. 8. — P. 239 — 245.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Stary G., Klein I., Kohlhofer S. Plasmacytoid dendritic cells express TRAIL and induce CD4 + T-cell apoptosis in HIV-1 viremic patients // Blood. — 2009. — Vol. 114. — P. 3854 — 3863.</mixed-citation><mixed-citation xml:lang="en">Stary G., Klein I., Kohlhofer S. Plasmacytoid dendritic cells express TRAIL and induce CD4 + T-cell apoptosis in HIV-1 viremic patients // Blood. — 2009. — Vol. 114. — P. 3854 — 3863.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Steinman R.M. The dendritic cell system and its role in immunogenicity // Annu. Rev. Immunol. — 1991. — Vol. 9. — P. 271 —296.</mixed-citation><mixed-citation xml:lang="en">Steinman R.M. The dendritic cell system and its role in immunogenicity // Annu. Rev. Immunol. — 1991. — Vol. 9. — P. 271 —296.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
